John L. Higgins, Chief Executive Officer at LIGAND PHARMACEUTICALS INC (LGND), bought 3,700 shares at $95.45 ($353K) on 2019-07-31, disclosed to the SEC on 2019-07-31.
Seasonal purchase ($353k) by Chief Executive Officer — this insider has traded LGND in July in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $95.45 | 1,850 | $177K | 50.0% |
| 2 | $95.45 | 1,850 | $177K | 50.0% |
| Total | $95.45 avg | 3,700 | $353K | 100% |
| Filing → |
| OABI | BUY | 2025-03-21 | $9K | — | Filing → |
| OABI | BUY | 2025-03-20 | $591K | — | Filing → |
| TECH | SELL | 2024-05-16 | $335K | — | Filing → |